|
ZC3H12C expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.671220E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.309600E-01 |
| Normal-vs-Stage2 |
3.953200E-01 |
| Normal-vs-Stage3 |
5.789000E-04 |
| Normal-vs-Stage4 |
3.90410000000729E-05 |
| Stage1-vs-Stage2 |
8.873900E-02 |
| Stage1-vs-Stage3 |
9.83950000366107E-08 |
| Stage1-vs-Stage4 |
1.33130000357085E-08 |
| Stage2-vs-Stage3 |
1.438990E-01 |
| Stage2-vs-Stage4 |
4.035800E-02 |
| Stage3-vs-Stage4 |
3.048800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.025200E-01 |
| Normal-vs-AfricanAmerican |
7.287800E-02 |
| Normal-vs-Asian |
7.253400E-01 |
| Caucasian-vs-AfricanAmerican |
3.385400E-01 |
| Caucasian-vs-Asian |
9.327200E-01 |
| AfricanAmerican-vs-Asian |
6.041400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.830200E-02 |
| Normal-vs-Female |
9.573000E-01 |
| Male-vs-Female |
4.171900E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.377540E-02 |
| Normal-vs-Age(41-60Yrs) |
4.093800E-01 |
| Normal-vs-Age(61-80Yrs) |
1.640160E-01 |
| Normal-vs-Age(81-100Yrs) |
7.486600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.096100E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.980100E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.660400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.624200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.773800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.786400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
7.090200E-02 |
| Normal-vs-Grade 2 |
2.615200E-01 |
| Normal-vs-Grade 3 |
1.579970E-02 |
| Normal-vs-Grade 4 |
7.2811999762834E-09 |
| Grade 1-vs-Grade 2 |
3.834000E-01 |
| Grade 1-vs-Grade 3 |
1.318180E-02 |
| Grade 1-vs-Grade 4 |
9.14290000042506E-07 |
| Grade 2-vs-Grade 3 |
1.417480E-04 |
| Grade 2-vs-Grade 4 |
2.64399613314481E-12 |
| Grade 3-vs-Grade 4 |
5.5771999999954E-05 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
2.902000E-03 |
| Normal-vs-ccB subtype |
4.005300E-04 |
| ccA subtype-vs-ccB subtype |
4.88387108532606E-13 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.200820E-01 |
| Normal-vs-N1 |
8.812200E-04 |
| N0-vs-N1 |
9.019700E-03 |
|
|
